Business · 20/07/2004Updated: 10/17/2026 · 1 min read
FDA Withdraws Six Outdated Guidances on Drug Approval Requirements
Summary
The Food and Drug Administration (FDA) is withdrawing six outdated guidances on the clinical evaluation and requirements for approval of certain classes of drugs, including radiopharmaceuticals and drugs for superficial bladder cancer, due to their limited usefulness to the pharmaceutical industry.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →